Work

Rationale and Design for a Multicenter, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects with Amyotrophic Lateral Sclerosis (P5.331)

FWCI:
Cites:
Cited by:
Related to: 10